Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 414

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 414
---
udited condensed financial statements. F-4

TABLE OF CONTENTS

IRIS ACQUISITION CORP CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)

| ​                                                                           | ​ | ​ | Nine Months EndedSeptember 30, 2024 |   |            |   | ​ | ​ | Nine Months EndedSeptember 30, 2023 |   |             |   | ​ |
|:----------------------------------------------------------------------------|:--|:--|:------------------------------------|:--|-----------:|:--|:--|:--|:------------------------------------|:--|------------:|:--|:--|
| Cash Flows from Operating Activities:                                       | ​ | ​ | ​                                   | ​ |          ​ | ​ | ​ | ​ | ​                                   | ​ |           ​ | ​ | ​ |
| Net loss                                                                    | ​ | ​ | ​                                   | $ | -2,035,985 | ​ | ​ | ​ | ​                                   | $ |    -739,623 | ​ | ​ |
| Adjustments to reconcile net loss to net cash used in operating activities: | ​ | ​ | ​                                   | ​ |          ​ | ​ | ​ | ​ | ​                                   | ​ |           ​ | ​ | ​ |
| Unrealized gain on change in fair value of warrant liabilities              | ​ | ​ | ​                                   | ​ |   -248,882 | ​ | ​ | ​ | ​                                   | ​ |    -442,726 | ​ | ​ |
| Unrealized gain on change in fair value of derivative liability             | ​ | ​ | ​                                   | ​ |     -2,202 | ​ | ​ | ​ | ​                                   | ​ |           — | ​ | ​ |
| Forgiveness of unrelated vendor payables                                    | ​ | ​ | ​                                   | ​ |          — | ​ | ​ | ​ | ​                                   | ​ |    -275,000 | ​ | ​ |
| Interest income on investments held in Trust Account                        | ​ | ​ | ​                                   | ​ |   -113,590 | ​ | ​ | ​ | ​                                   | ​ |    -506,550 | ​ | ​ |
| Accretion of discount on related party loans                                | ​ | ​ | ​                                   | ​ |      1,339 | ​ | ​ | ​ | ​                                   | ​ |           — | ​ | ​ |
| Changes in operating assets and liabilities:                                | ​ | ​ | ​                                   | ​